wound closure device investor presentation 12 24 13

18
Contact Richard Hunsaker [email protected] 702-617-4326 MedClosure, Inc. Innovation in mechanical wound closure and surgical closure devices IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected] 1

Upload: rehun

Post on 13-Jul-2015

181 views

Category:

Technology


2 download

TRANSCRIPT

Page 1: Wound closure device investor presentation 12 24 13

Contact Richard Hunsaker

[email protected] 702-617-4326

MedClosure, Inc. Innovation in mechanical wound closure and surgical closure devices

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

1

Page 2: Wound closure device investor presentation 12 24 13

Market unique medical devices that meet significant unmet needs in the Consumer, EMT and Surgical/Medical categories

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

2

Objective

Page 3: Wound closure device investor presentation 12 24 13

3

MedClosure, Inc. a Nevada Corporation with unique proprietary motorized wound/surgical closure products for three separate markets. Fix·A·Cut™ a compact automatic device for closing cuts that may otherwise require stitches. EMTClose™ a motorized wound closure device engineered for use by EMS/Paramedics/Military Medics. SurgClose™ a specialty motorized surgical closure device for use in unique surgical (ie. foot/ankle) situations where immediate incision closure may require stretching of the surrounding dermis to accomodate sutures.

MedClosure, Inc.

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 4: Wound closure device investor presentation 12 24 13

4

Fix·A·Cut™ - Opportunity

•NEED

• There were over 136 million visits to emergency rooms in 2012 • The average ER wait to stitch a cut is several hours • Many of these cuts can be closed quickly and easily with Fix·A·Cut™ • Hikers, campers, sporting events, playground…first aid kits.

• The Market is wide open. • There are presently no competitors with automatic (motorized) devices

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 5: Wound closure device investor presentation 12 24 13

5

Product - Fix·A·Cut™ •Easy to use in emergency situations

1) Remove from sterile bag 2) Remove adhesive covers 3) Position on each side of wound 4) Draw to close, one button 5) Wound closed, pressure applied & bleeding controlled 6) For longer cuts, use more than 1 device

• Features • Pre Assembled • High Tech adhesive base • Durable

• Benefits • Can be mounted in seconds, saving precious time • Strong enough to hold in place while transporting patient • Holds wound closed & applies pressure to stop bleeding

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 6: Wound closure device investor presentation 12 24 13

6

Fix·A·Cut™

Motorized Closing Device Anchor

Motorized

Page 7: Wound closure device investor presentation 12 24 13

7

EMTClose™ - Opportunity

•NEED

• Over 3 million people per year are injured in auto accidents • Over 40,000 Injuries due to Industrial Accidents • Over 60,000 Injuries due to crime/violence • Since 2001 66% casualties in Afghanistan are from IEDs • EMT/Medic priorities at site of incident

• Check breathing • Stop Bleeding • Stabilize/Transport

• The Markets is wide open. • There are presently no competitors

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 8: Wound closure device investor presentation 12 24 13

8

Product - EMTClose™ • Larger Version of Fix-A-Cut

1) Multiple units may be used •Easy to use in emergency situations

1) Remove from sterile bag 2) Remove adhesive covers 3) Position on each side of wound 4) Draw to close, one button 5) Wound closed, pressure applied & bleeding controlled

• Features • Pre Assembled • High Tech adhesive base • Durable

• Benefits • Can be mounted in seconds, saving precious time • Strong enough to hold in place while transporting patient • Holds wound closed & applies pressure to stop bleeding

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 9: Wound closure device investor presentation 12 24 13

9

EMTClose™

Motorized

Motorized

Motor Driven Closure

Anchor

*Devices are single units. Multiple devices can be used for larger wounds

Page 10: Wound closure device investor presentation 12 24 13

10

SurgClose™- Opportunity •NEED

• A cost effective post surgery motorized closure device that can be utilized in specialty surgery situations where the post-surgical incision is difficult to close due to tight surrounding skin •1,600+ Trauma Centers • 6,000+ Hospitals • 135,000+ Surgeons

• Currently one major player in this market • DermaClose (Wound Care Technologies)

• Current sales nearly $200MM per year • Single use kit sells to hospital/doctor for $700

• SurgClose™

• More user friendly • Attached with adhesives rather than barbs

• Many times staples not necessary • Price point nearly 40% less than DermaClose • Motorized

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 11: Wound closure device investor presentation 12 24 13

11

Product - SurgClose™ •Easy to use

1) Remove from sterile bag 2) Remove adhesive covers 3) Position proper sized tabs on each side of incision 4) Position tab with motor in center 5) Lace the line through the tabs 6) Push button on motor to activate closure

1) Continue until incision is closed 7) Once Incision closed: remove SurgClose™ and suture

• Features • Pre Assembled • High Tech adhesive base • Slots for staples • Durable

• Benefits • Can be mounted in seconds, saving precious time • Strong enough to hold, in most cases without staples • Expedites incision closure process

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 12: Wound closure device investor presentation 12 24 13

12

Top view

anchor plate attaches to skin

medical adhesive on underside

Indentations for medical staples (if needed)

Motorized

SurgClose™

Page 13: Wound closure device investor presentation 12 24 13

13

MedClosure Products •Easy utilization • No assembly required • Adhesive base

•many times, staples not necessary • 510k exempt • non invasive

• low product liability insurance • Profitable • Versatile • Intellectual Property

• Patented (pending) • EMTClose™ #61/711,113 • SurgClose™ #61/810,376

• Product cost below $10 • Price points: $19 - Fix∙A∙Cut $49-EMTClose* $425-SurgClose • Gross margin 90% - 97% • Net Profit after taxes nearly 60%

*single unit IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

Page 14: Wound closure device investor presentation 12 24 13

• Sell through appropriate consumer & medical channels

• Target Markets • Fix∙A∙Cut

• Direct response marketing, Major retailers • EMTClose

• EMT/Fire Stations, Municipal Governments, Military •SurgClose

• Surgical Centers, Hospitals, Emergency Rooms, Surgeons, Military

• Utilize our current network of sales talent and add as needed

• Sales/Marketing Management Background: • Over 50 years combined consumer/pharmaceutical/medical experience

• majority in top management

• Key Sales/Marketing Team Players identified, ready to start

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

14

Sales/Marketing

Page 15: Wound closure device investor presentation 12 24 13

15

Richard Hunsaker - President

Alan Xenakis, MD, ScD, MPH, MS – Chief Medical Officer

Rod Jones – Chief Marketing Officer

J. Scott Bierly – Director of Sales

Over 30 years in Sales/Marketing in Consumer/Pharmaceutical/Medical products. In his 17 years with Colgate Palmolive, Richard was Director of Sales for the pharmaceutical division and part of the operating management. Over 15 years as principal of RH Sales Consulting, LLC. Extensive experience in developing and launching new products in consumer and medical arenas.

Rod has operating his own marketing business for over 20 years. He has extensive experience in direct to consumer and retail marketing. Rod’s experience and insights make him a vital component to the MedClosure team.

As a physician, broadcaster and former CEO, Dr. Xenakis brings a wealth of knowledge and energy to the MedCosure Team. At CBS TV in Boston, Dr. Xenakis was nominated for an EMMY 13 times and the recipient once. He has developed, produced and hosted numerous health related radio and TV programs at stations across the country…many of which were syndicated. Dr. Xenakis has a medical degree from Boston University School of Medicine and a Master of Public Health from Harvard University.

Scott has been in pharmaceutical/medical sales and sales management for over 30 years. He has extensive experience in training, developing and managing sales representatives. Most recently, he was National Sales Manager for the national drug distributor, Harvard Drug.

Page 16: Wound closure device investor presentation 12 24 13

Capital required: $500,000 - $1 MM

High ROI Gross Margin – over 90% Net Profit (after tax) nearly 60%

Exit Strategy Acquisition or Sale 5-8 years $50MM - $100MM+ 10x – 30x plus ROI

Reverse Merger

Detailed Business Plan Available

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

16

Investment Opportunity

Page 17: Wound closure device investor presentation 12 24 13

Operation costs (legal, accounting, office) $75,000 - $100,000

Product Development/Die Production $100,000 - $125,000

Sales/Marketing (reps, samples, materials) $100,000 - $125,000

Rent/Packaging (labor) $50,000

Inventory & Production (assembly/components/sterilization) $100,000 - $150,000

IMPORTANT: By accepting and reading this document you are providing your consent to the terms of confidentiality (last page). If you do not agree, delete all electronic files and destroy all hard copies with a return notification to [email protected]

17

Use of Funds

Page 18: Wound closure device investor presentation 12 24 13

Confidential Non-Disclosure agreement between MedClosure, Inc. (Discloser) & recipient of document (Recipient) Discloser possesses certain ideas and information relating to a custom and proprietary design that is confidential and proprietary to Discloser (hereinafter "Confidential Information"); and WHEREAS the Recipient is willing to receive disclosure of the Confidential Information pursuant to the terms of this Agreement for the purpose of assisting/consulting, marketing or any scope of the relationship based on this product: NOW THEREFORE, in consideration for the mutual undertakings of' the Discloser and the Recipient under this Agreement, the parties agree as follows: I. Disclosure. Discloser agrees to disclose, and Receiver agrees to receive the Confidential Information. 2. Confidentiality. 2.1 No Use. Recipient agrees not to use the Confidential Information in any way, or to manufacture or test any product embodying Confidential Information exceptfor the purpose set forth above. 2.2 No Disclosure. Recipient agrees to use its best efforts to prevent and protect the Confidential Information. or any part thereof. from disclosure to any person other than Recipient's employees having a need for disclosure in connection with Recipient's authorized use of the Confidential Information. 2.3 Protection of Secrecy. Recipient agrees to take all steps reasonably necessary to protect the secrecy of the Confidential Information, and to prevent the Confidential Information from falling into the public domain or into the possession of unauthorized persons. 3. Limit on Confidential Information. Confidential Information shall not be deemed proprietary and the Recipient shall have no obligation with respect to such information where the information:(a) was known to Recipient prior to receiving any of the Confidential Information from Discloser;(b) has become publicly known through no wrongful act of Recipient:(c) was received by Recipient without breach of this Agreement from a third party without restriction as to the use and disclosure of the information;(d) was independently developed by Recipient without use of the Confidential Information Ownership of Confidential Information. Recipient agrees that all Confidential Information shall remain the property of Discloser, and that Discloser may use such Confidential Information for any purpose without obligation to Recipient. Nothing contained herein shall be construed as granting or implying any transfer of rights to Recipient in the Confidential Information. or any patents or other intellectual property protecting or relating to the Confidential Information. Term and Termination. The obligations of this Agreement shall be in effect for a period of two years. Survival of Rights and Obligations. This Agreement shall be binding upon. inure to the benefit of. and be enforceable by (a) Discloser, its successors, and assigns; and (b) Recipient. its successors and assigns.

15